These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9531587)
1. New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides. Lecomte-Raclet L; Alemany M; Sequira-Le Grand A; Amiral J; Quentin G; Vissac AM; Caen JP; Han ZC Blood; 1998 Apr; 91(8):2772-80. PubMed ID: 9531587 [TBL] [Abstract][Full Text] [Related]
2. Dual structural requirements for multilineage hematopoietic-suppressive activity of chemokine-derived peptides. Lecomte-Raclet L; Rholam M; Alemany M; Lazar N; Simenel C; Delepierre M; Han ZC; Cohen P; Caen JP Biochemistry; 2000 Aug; 39(31):9612-22. PubMed ID: 10924159 [TBL] [Abstract][Full Text] [Related]
3. A 13-24 C-terminal peptide related to PF4 accelerates hematopoietic recovery of progenitor cells in vivo in mice treated with 5-fluorouracil. Aïdoudi S; Lebeurier I; Amiral J; Quentin G; Caen JP; Han ZC Int J Hematol; 1997 Dec; 66(4):435-44. PubMed ID: 9479870 [TBL] [Abstract][Full Text] [Related]
4. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Han ZC; Sensébe L; Abgrall JF; Brière J Blood; 1990 Mar; 75(6):1234-9. PubMed ID: 2310823 [TBL] [Abstract][Full Text] [Related]
5. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Han ZC; Lu M; Li J; Defard M; Boval B; Schlegel N; Caen JP Blood; 1997 Apr; 89(7):2328-35. PubMed ID: 9116276 [TBL] [Abstract][Full Text] [Related]
6. In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil. Aidoudi S; Guigon M; Lebeurier I; Caen JP; Han ZC Br J Haematol; 1996 Sep; 94(3):443-8. PubMed ID: 8790139 [TBL] [Abstract][Full Text] [Related]
7. Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin. Lebeurier I; Basara N; Aïdoudi S; Amiral J; Caen JP; Han ZC Br J Haematol; 1996 Jan; 92(1):29-34. PubMed ID: 8562407 [TBL] [Abstract][Full Text] [Related]
8. [The hemoprotective effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP]. Han Z; Cai Y; Aidoudi S Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):33-5. PubMed ID: 11498842 [TBL] [Abstract][Full Text] [Related]
9. Chemokine regulation of human megakaryocytopoiesis. Gewirtz AM; Zhang J; Ratajczak J; Ratajczak M; Park KS; Li C; Yan Z; Poncz M Blood; 1995 Oct; 86(7):2559-67. PubMed ID: 7670101 [TBL] [Abstract][Full Text] [Related]
10. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. Daly TJ; LaRosa GJ; Dolich S; Maione TE; Cooper S; Broxmeyer HE J Biol Chem; 1995 Oct; 270(40):23282-92. PubMed ID: 7559482 [TBL] [Abstract][Full Text] [Related]
11. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy]. Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183 [TBL] [Abstract][Full Text] [Related]
12. Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis. Dudek AZ; Nesmelova I; Mayo K; Verfaillie CM; Pitchford S; Slungaard A Blood; 2003 Jun; 101(12):4687-94. PubMed ID: 12586630 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. Gewirtz AM; Calabretta B; Rucinski B; Niewiarowski S; Xu WY J Clin Invest; 1989 May; 83(5):1477-86. PubMed ID: 2523411 [TBL] [Abstract][Full Text] [Related]
14. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells. Gallicchio VS; Hughes NK; Hulette BC; Noblitt L J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611 [TBL] [Abstract][Full Text] [Related]
15. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura. Han ZC; Bellucci S; Tenza D; Caen JP Br J Haematol; 1990 Apr; 74(4):395-401. PubMed ID: 2140694 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the human burst-forming unit-megakaryocyte. Briddell RA; Brandt JE; Straneva JE; Srour EF; Hoffman R Blood; 1989 Jul; 74(1):145-51. PubMed ID: 2473794 [TBL] [Abstract][Full Text] [Related]
18. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors. Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726 [TBL] [Abstract][Full Text] [Related]
19. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells. Gallicchio VS; Hughes NK Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625 [TBL] [Abstract][Full Text] [Related]
20. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Broxmeyer HE; Cooper S; Lu L; Hangoc G; Anderson D; Cosman D; Lyman SD; Williams DE Blood; 1991 May; 77(10):2142-9. PubMed ID: 1709371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]